Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Launching soon: New joint health hub for healthcare professionals

Launching soon: New joint health hub for healthcare professionals


Lanes Health is set to launch a new Joint Health Hub, designed to support both healthcare professionals and their patients. This dedicated professional portal, hosted on the GOPO® Joint Health website, offers a user-friendly interface, providing quick and easy access to essential resources and information for comprehensive joint health management.

GOPO® Joint Health provides a scientifically documented rose-hip powder that is made using a specialist process to ensure that the powder retains high levels of the galactolipid GOPO®. Rose-hip may play a valuable role in the care of joints and joint tissues. The galactolipid GOPO® has been studied in over 20 scientific trials.

For more information visit the GOPO® Website: www.gopo.co.uk

Or call: 01452 524012

More For You

Students from retail sector using bursary aid for postgraduate education

The charity has given £28 million worth of financial aid to postgraduate students.

Bursary applications open for pharmacy students

A leading charity that provides financial aid for the families of those working in the pharmacy, convenience and grocery sector, has announced postgraduate bursary applications open for 2025/2026.

The Leverhulme Trade Charities Trust (LTCT) bursary scheme is open to students on postgraduate courses, whose parent, carer, spouse is employed in an eligible profession, such as convenience retailer, supermarket store worker, or pharmacy technician.

Keep ReadingShow less
The NHS has changed payment structure for consultations

The NHS has changed payment structure for consultations

Maximising new medicine services can be a game changer for pharmacists

Adele Curran, chief operations officer at RWA Pharmacy Ltd, looks at the changes to NMS and the financial opportunities they offer for Community Pharmacies

English pharmacies have been delivering new medicine services (NMS) since October 2011. They have successfully increased the effective use of medicines across their communities and also increased their revenue through the claiming structure.

Keep ReadingShow less
Camizestrant Cuts Breast Cancer Progression by 50% – New Hope

There was a 56 per cent reduction in the risk of disease progression or death

Pic credit: iStock

Blood test-guided treatment with AstraZeneca pill cuts breast cancer progression risk

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard therapies cut the risk of disease progression or death by half, a finding that could be practice changing, experts said on Sunday.

The results, presented at the American Society of Clinical Oncology meeting in Chicago, mark the first use of a blood test called a liquid biopsy to indicate the need for a change in treatment in women with a common form of breast cancer, even before tumor growth can be detected on imaging.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

Acute sore throats had the most consultations

Pic credit: istock

Pharmacy First has already seen over five million patients

The Pharmacy First scheme has helped over five million patients with minor illnesses, according to NHS England.

Around 2.4 million people received help without booking an appointment at their local pharmacy for seven common conditions including sore throat, earache or shingles.

Keep ReadingShow less
122 pharmacists were successful in achieving credentials

122 pharmacists were successful in achieving credentials

Pic credit: Istock

RPS reports record increase in credentialing submissions

The Royal Pharmaceutical Society (RPS) has revealed that credentialing submissions rose by 190 per cent compared to last year, with 226 assessments completed and 122 pharmacists successfully credentialed.

The data also reveals increasing uptake in primary care settings and continued strong representation from hospital-based pharmacists.

Keep ReadingShow less